Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors

Clinical trial NCT02614456 · COMPLETED

Trial details

NCT number: NCT02614456
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2015-12-11
Primary completion: 2019-06-12
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.